Dr. Farid Ahmad
|
Home
>>
Research Staff >>
Farid Ahmed - Ph.D |
|
|
|
Assistant Professor
Coordinator of Flowcytometry and Molecular genetics Service Units
Cancer Genomics, Tissue Culture & Regenerative Medicine Research Groups
Dr. Ahmed completed his Ph.D. in human biology from the Ludwig Maximilians University, Munich, in 2006. He performed his post-doctoral studies at the Helmholtz Zentrum Muenchen and the Clinical Co-operative Group-Leukemia in Munich where he concentrated his efforts on carrying out functional screens using the mouse models to characterize hematopoietic stem cell (HSC) regulators involved in leukemia. At the CEGMR, Dr. Ahmed played a key role in the development of the Tissue Culture and Flow Cytometry Units. He is currently in-charge of the Flow Cytometry and Cell Sorting Unit and the Molecular Biology Unit of the CEGMR.
One of Dr. Ahmed’s current research interests is studying the molecular regulation of normal and malignant hematopoiesis and HSC self-renewal with the hope to identify underlying processes that lead to leukemic transformation and progression. Projects in Dr. Ahmed’s group focus on identification and characterization of candidate leukemic stem cell (LSC) in hematopoietic malignancies and therapeutic targeting of the leukemic cells that drive human leukemia.
Projects in Dr. Ahmed’s research group include stem cell and angiogenesis studies in diabetes and leukemia. He has currently two research grants supported by the KACST.
Dr. Ahmed is currently a member of several scientific societies such as: International Society for Stem Cell Research (ISSCR), European Hematology Association (EHA) and ISEH - Society for Hematology and Stem Cells.
Selected Publications:
1. Next Generation Sequencing of Acute Myeloid Leukemia: Influencing Prognosis
Ilyas A M, Ahmad S, Faheem M, Naseer MI, Kumosani TA, Al-Qahtani MH, Gari M, Ahmed F
BMC Genomics 2015, 16(Suppl 1):S5
2. Weaver JU. Reference Genes for Expression Studies in Hypoxia and Hyperglycemia Models in Human Umbilical Vein Endothelial Cells
Bakhashab S, Lary S, Ahmed F, Schulten HJ, Bashir A, Ahmed FW, Al-Malki AL, Jamal HS, Gari MA
G3 (Bethesda). 2014
3. The vent-like homeobox gene VENTX promotes human myeloid differentiation and is highly expressed in acute myeloid leukemia
Rawat VP, Arseni N, Ahmed F, Mulaw MA, Thoene S, Heilmeier B, Sadlon T, D'Andrea RJ, Hiddemann W, Bohlander SK, Buske C, Feuring-Buske M
Proc Natl Acad Sci U S A. 2010 Sep 10
4. Constitutive Expression of the ATP-Binding Cassette Transporter ABCG2 Enhances the Growth Potential of Early Human Hematopoietic Progenitors.
Ahmed F, Arseni N, Hiddemann W, Buske C, Feuring-Buske M
Stem Cells. 2008 Mar;26(3):810-8
5. BH3 mimetic ABT-737 neutralizes resistance to FLT3 inhibitor treatment mediated by FLT3 -independent expression of BCL2 in primary AML blasts
Kohl TM, Hellinger C, Ahmed F, Buske C, Hiddemann W, Bohlander SK, Spiekermann K
Leukemia. 2007 Aug;21(8):1763-72
|
Dr. Farid Ahmed
|
|
Last Update
2/15/2015 2:08:47 PM
|
|
|